Works matching IS 22965270 AND DT 2016 AND VI 39 AND IP 1/2
Results: 19
Editorial Board / Contents / Imprint / Guidelines for Authors.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 1, doi. 10.1159/000444105
- Publication type:
- Article
Pathogenesis, Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Exciting Times.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 8, doi. 10.1159/000443821
- By:
- Publication type:
- Article
Concepts of Chronic Lymphocytic Leukemia Pathogenesis: DNA Damage Response and Tumor Microenvironment.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 9, doi. 10.1159/000443820
- By:
- Publication type:
- Article
Optimale Mobilisierungsstrategien für den individuellen Patienten.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. I, doi. 10.1159/000444403
- Publication type:
- Article
Abirateronacetat: 43 Monate Überleben bei frühem Beginn.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. V, doi. 10.1159/000444402
- Publication type:
- Article
Risk-Adapted Therapy in Early-Stage Chronic Lymphocytic Leukemia.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 18, doi. 10.1159/000443013
- By:
- Publication type:
- Article
State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 25, doi. 10.1159/000443903
- By:
- Publication type:
- Article
Genomic Features: Impact on Pathogenesis and Treatment of Chronic Lymphocytic Leukemia.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 34, doi. 10.1159/000443906
- By:
- Publication type:
- Article
Outpatient Management of Patients with Immune Thrombocytopenia (ITP) by Hematologists 1995-2014.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 41, doi. 10.1159/000442769
- By:
- Publication type:
- Article
Natural Killer/T Cell Lymphoma, Nasal Type: A Retrospective Clinical Analysis in North-Western China.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 45, doi. 10.1159/000442763
- By:
- Publication type:
- Article
Reactive Oxygen Species Mediate TNF-⍺ Cytotoxic Effects in the Multidrug-Resistant Breast Cancer Cell Line MCF-7/MX.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 54, doi. 10.1159/000442144
- By:
- Publication type:
- Article
Tumor Heterogeneity Assessed by 18F-FDG PET/CT Is Not Significantly Associated with Nodal Metastasis in Breast Cancer Patients.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 61, doi. 10.1159/000442760
- By:
- Publication type:
- Article
Ongoing Clinical Trials.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 67, doi. 10.1159/000444031
- Publication type:
- Article
A Study to Compare the Efficacy and Safety of Obinutuzumab + Venetoclax versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL14).
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 69, doi. 10.1159/000443908
- Publication type:
- Article
Reports of Oncological Societies.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 73, doi. 10.1159/000444107
- Publication type:
- Article
PharmaForum.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 78, doi. 10.1159/000444225
- Publication type:
- Article
PharmaForum.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 80, doi. 10.1159/000444226
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 83, doi. 10.1159/000444227
- Publication type:
- Article
Meetings and Conferences.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 90, doi. 10.1159/000444030
- Publication type:
- Article